Senators Coons, Rubio Reintroduce Legislation To Improve Domestic Biopharmaceutical Manufacturing Capabilities For Emerging Public Health Threats
January 28, 2023
January 28, 2023
WASHINGTON, Jan. 28 -- Sen. Christopher Coons, D-Delaware, issued the following news release:
U.S. Senators Chris Coons (D-Del.) and Marco Rubio (R-Fla.) reintroduced the Agility in Manufacturing Preparedness Act this week to require the U.S. Department of Health and Human Services (HHS) and the Biomedical Advanced Research and Development Authority (BARDA) to contract with the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) for the purpose of evaluati . . .
U.S. Senators Chris Coons (D-Del.) and Marco Rubio (R-Fla.) reintroduced the Agility in Manufacturing Preparedness Act this week to require the U.S. Department of Health and Human Services (HHS) and the Biomedical Advanced Research and Development Authority (BARDA) to contract with the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) for the purpose of evaluati . . .